Ted the direct effects of the bacterial species on PBMCs. Thus, other cells, e.g. monocytes, 
may produce IL-10, which could then explain these contradictory results. Several potential mechanisms, by which lactobacilli potentially exert their immunosuppressive effects, have been reported. For instance, lactic acid produced by lactobacilli, has been shown to degrade gram-positive bacterial lipoteichoic acid and reduce pathogen-induced cell cytotoxicity [29]. In addition, metabolites from lactic acid producing bacteria have been reported to reduce TLR-induced inflammatory responses [30]. Also, T helper responses, in PBMCs cultures after PHA stimulation, were down regulated, by lactobacilli, in an monocyte-induced IL-10 dependent manner [31] supporting our in vitro findings of increased IL10 levels in LGG stimulated cultures.Supplementation with different Lactobacillus species has been used in allergy prevention, but the results vary between studies [32?5]. Still, several probiotic strains have been demonstrated to exert immunomodulatory functions. For example supplementation of L. gasseri to allergic school-age children suppressed their PHAstimulated cytokine responses of IL-12, IL-13 and IFN-c followed by a reduction of clinical symptom scores [36], which is interesting in relation to the findings presented in our study. We should acknowledge the relatively low number of individuals in this study, and the findings need to be confirmed in larger studies. However, we only report results that are consistent at several early time points, thus increasing the probability of true findings. Further, it should be mentioned that results of our in vitro 16574785 studies are based on the effects of bacterial supernatants that may not represent the in vivo situation in the intestinal tract. In conclusion, we demonstrate that the early infant microbiota associates with the numbers of cytokine-secreting cells at two years of age, in a genus- and species specific manner, which we further confirmed by in vitro stimulations. As different species and strains have different capacity to alter the cytokine responses later in life, the early-life gut microbiota could modulate the risk of developing inflammatory conditions like allergic disease.AcknowledgmentsA special thanks to Monica Nordlund, Anna Stina Ander, Ankie Soderlund, Anna-Karin Sigfrinius and Jacob Taku Minang for their ?invaluable assistance.Author ContributionsConceived and designed the experiments: MAJ SR CN ESE. Performed the experiments: MAJ SSH YH MTB. Analyzed the data: MAJ SSH CN ESE. Contributed reagents/materials/analysis tools: SR MTB CN ESE. Wrote the paper: MAJ ESE.
The involvement of ETS genes in cancer was first demonstrated by the presence of the oncogene v-ets as part of the gag-myb-ets transforming fusion protein of an avian retrovirus, E26 [1]. Their importance in human carcinogenesis is supported by the observations that ETS genes are implicated in chromosomal translocations, giving rise to fusion proteins that play an important role in the genesis of several hematological malignances, soft tissue tumors and carcinomas [2]. The ETS family of transcription factors is one of the largest families of transcription Tunicamycin chemical information regulators (27 members in the human genome), and plays an important role in diverse biological processes, including cell AVP chemical information proliferation, apoptosis,differentiation, lymphoid and myeloid cell development, angiogenesis and invasiveness [3?]. It is characterized by an 85 amino acidic, hig.Ted the direct effects of the bacterial species on PBMCs. Thus, other cells, e.g. monocytes, may produce IL-10, which could then explain these contradictory results. Several potential mechanisms, by which lactobacilli potentially exert their immunosuppressive effects, have been reported. For instance, lactic acid produced by lactobacilli, has been shown to degrade gram-positive bacterial lipoteichoic acid and reduce pathogen-induced cell cytotoxicity [29]. In addition, metabolites from lactic acid producing bacteria have been reported to reduce TLR-induced inflammatory responses [30]. Also, T helper responses, in PBMCs cultures after PHA stimulation, were down regulated, by lactobacilli, in an monocyte-induced IL-10 dependent manner [31] supporting our in vitro findings of increased IL10 levels in LGG stimulated cultures.Supplementation with different Lactobacillus species has been used in allergy prevention, but the results vary between studies [32?5]. Still, several probiotic strains have been demonstrated to exert immunomodulatory functions. For example supplementation of L. gasseri to allergic school-age children suppressed their PHAstimulated cytokine responses of IL-12, IL-13 and IFN-c followed by a reduction of clinical symptom scores [36], which is interesting in relation to the findings presented in our study. We should acknowledge the relatively low number of individuals in this study, and the findings need to be confirmed in larger studies. However, we only report results that are consistent at several early time points, thus increasing the probability of true findings. Further, it should be mentioned that results of our in vitro 16574785 studies are based on the effects of bacterial supernatants that may not represent the in vivo situation in the intestinal tract. In conclusion, we demonstrate that the early infant microbiota associates with the numbers of cytokine-secreting cells at two years of age, in a genus- and species specific manner, which we further confirmed by in vitro stimulations. As different species and strains have different capacity to alter the cytokine responses later in life, the early-life gut microbiota could modulate the risk of developing inflammatory conditions like allergic disease.AcknowledgmentsA special thanks to Monica Nordlund, Anna Stina Ander, Ankie Soderlund, Anna-Karin Sigfrinius and Jacob Taku Minang for their ?invaluable assistance.Author ContributionsConceived and designed the experiments: MAJ SR CN ESE. Performed the experiments: MAJ SSH YH MTB. Analyzed the data: MAJ SSH CN ESE. Contributed reagents/materials/analysis tools: SR MTB CN ESE. Wrote the paper: MAJ ESE.
The involvement of ETS genes in cancer was first demonstrated by the presence of the oncogene v-ets as part of the gag-myb-ets transforming fusion protein of an avian retrovirus, E26 [1]. Their importance in human carcinogenesis is supported by the observations that ETS genes are implicated in chromosomal translocations, giving rise to fusion proteins that play an important role in the genesis of several hematological malignances, soft tissue tumors and carcinomas [2]. The ETS family of transcription factors is one of the largest families of transcription regulators (27 members in the human genome), and plays an important role in diverse biological processes, including cell proliferation, apoptosis,differentiation, lymphoid and myeloid cell development, angiogenesis and invasiveness [3?]. It is characterized by an 
85 amino acidic, hig.
